97人妻熟女成人免费视频色戒-天天狠天天天天透在线-大屁股熟女一区二区三区-欧美性xxxx极品少妇-久久亚洲精品成人av无码网站

Home>About Livzon>Company Profile

Profile of Zhuhai Livzon Diagnostics Inc.
Zhuhai Livzon Diagnostics Inc. (hereinafter referred to as “Livzon Diagnostics”) was established in 1989. It is the first high-tech subsidiary of the listed company, Livzon Pharmaceutical Group (A-share and H-share listed company), who specializing in in-vitro diagnostics in research, developing, manufacturing and marketing of diagnosis products and automation equipment. Livzon Diagnostics is one of the earliest in vitro diagnostic products manufacturing enterprises in China, a national high-tech enterprise.

Livzon Diagnostics has established many technical platforms such as Enzyme-linked Immunoassay, lateral flow chromatography, Microorganisms testing, Molecular testing, Multiple-detection Immunoassay, Single-test Chemiluminescence immunoassay, Mast Cell Degranulation Test for Allergy, etc. Meanwhile, Livzon Diagnostics also has fully automatic equipment development capability. The products cover many disease areas such as infectious diseases, respiratory infection, tumor marker detection, drug concentration monitoring, autoimmunity, allergen detection, and blood safety. Therefore, Livzon Diagnostics has high market share in respiratory infections, infectious diseases, and drug concentration monitoring with market share as high as 50% -90%.

Zhuhai Livzon Diagnostics Inc.  has equipped with its industrialization base for Research and Development, Production and Office use, which covers an area of more than 23,000 square meters, construction area of more than 44,000 square meters, including 6000 square meters for Research and Development, which attracts professional elite talents from Laboratory Science, Biological engineering and many other fields. Zhuhai Livzon Diagnostics Inc. owns 5 Research and Development teams spread in 3 Research and Development centers, which located in Zhuhai, Shanghai and Suzhou city. The total Research and Development personnel accounted for nearly 20% , meanwhile the annual Research and Development investment reaches more than 10% of Sales Revenue. Beside its independent Research and Development, Zhuhai Livzon Diagnostics Inc. has established long-term successful cooperation with many first-class International Biomedical Enterprises such as Fujirebro from Japan, Siemens in Germany, and MP company (USA), which has enhanced its comprehensive service capabilities. Zhuhai Livzon Diagnostics Inc. has won the title of honor as "National High-tech Enterprises", "In vitro diagnostic Engineering Technology Research Center of Guangdong Province ", "Guangdong Provincial Enterprise Technology Center", "Innovative Enterprises of Guangdong Province " and the national "Post-doctoral Research Station". With a complete quality management system in production, Zhuhai Livzon Diagnostics Inc. has well achieved the national GMP certification, GSP certification and ISO13485/ISO9001 certification.
Livzon Overview
3
R&D centers
5
R&D teams
20%
scientific research personnel
50%
personnel with master degree
6000
R&D land area (m2)
作為中國IVD行業的先行者,麗珠試劑服務產品涵蓋了傳染性疾病、呼吸道感染、腫瘤標志物檢測、藥物濃度監測、自身免疫、過敏原檢測及血液安全等眾多領域,在呼吸道感染、傳染性疾病、藥物濃度監測等領域的市場占有率處于國內領先地位,多項產品市場占有率高達50%-90%。在2019年底中國爆發新型冠狀病毒的第一時間,麗珠試劑便投入研發,迅速研制出新型冠狀病毒(2019-nCoV)IgM / IgG抗體檢測試劑盒(膠體金法)產品,并獲證上市,助力國內外疫情防控。
  • 5.jpg

  • 6.jpg

Livzon Diagnostics Technology Theme Exhibition Hall
Focus on disease research · Create new detection technology

主站蜘蛛池模板: 亚洲男人的天堂在线播放| av不卡国产在线观看| 国产精品热久久无码av| 国产成人av一区二区三区| 无码精品黑人一区二区三区| 久久97超碰色中文字幕| 国产精品亚洲а∨怡红院| 日本强伦片中文字幕免费看 | 国产亚洲精品久久久久久男优| 久久久久久久无码高潮| 久久人人爽人人爽人人片av不| 超级碰碰| 少妇爆乳无码专区av无码| 成人综合网站| 131mm少妇做爰视频| 国产精品久久久久蜜芽| 四虎亚洲精品高清在线观看| 久久国产精品久久精品国产| 亚洲熟妇无码久久精品| 中文有码vs无码人妻| 狠狠色丁香婷婷久久综合| 麻豆文化传媒精品一区观看| 午夜寂寞少妇aaa片毛片| 久久97超碰色中文字幕| 无码人妻一区二区三区免费看 | 中文字幕久久精品波多野结百度 | 国产乱人伦偷精品视频免下载| 国产成人a∨麻豆精品| 欧美国产伦久久久久久久| 久久国产劲爆∧v内射| 又黄又爽又无遮挡免费的网站| 狠狠色噜噜狠狠狠狠av| 野外做受三级视频| 无码 制服 丝袜 国产 另类| 领导边摸边吃奶边做爽在线观看| 国产一区二区三区不卡av| 亚洲国产精品美女久久久久| 国产99视频精品免视看7| 内射人妻视频国内| 精品人伦一区二区三电影| 亚洲伊人成综合网|